Update on Male Osteoporosis

Thursday, March 30, 2023

3:45 PM – 4:45 PM

Location: Northbrook Ballroom

*Speaker(s)

Robert Adler, MD

Chief Endocrinology, Professor
Richmond Veterans Affairs Medical Center

Disclosure(s): Radius Health: Contracted Research (PI’s must provide disclosure in this category) (Terminated, December 31, 2021)

Handouts

*Moderator(s)

Rachel Pessah-Pollack, MD, FACE (she/her/hers)

Clinical Associate Professor
NYU Langone Hospitals

Disclosure(s): BI/Lilly: Consulting Fee (e.g., Advisory Boards) (Ongoing); Health Monitor: Consulting Fee (e.g., Advisory Boards) (Ongoing)

Disclosure(s):

Robert Adler, MD: Radius Health: Contracted Research (PI’s must provide disclosure in this category) (Terminated, December 31, 2021)

Rachel Pessah-Pollack, FACE: BI/Lilly: Consulting Fee (e.g., Advisory Boards) (Ongoing); Health Monitor: Consulting Fee (e.g., Advisory Boards) (Ongoing)

Despite long-held assumptions, osteoporotic fracture is a major cause of morbidity and mortality in men as it is in women. We will review the most recent evidence supporting the diagnostic and therapeutic management of osteoporosis in men.

Learning Objectives:

Recognize that osteoporosis is common in men and overall mortality after hip fracture is high.
Be able to devise appropriate evaluation of men with fracture and/or low bone density.
Guide osteoporosis management in men based on severity of fracture risk.